IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million
6th Dec 2024 12:11
Scancell Holdings PLC - Oxford, England-based developer of immunotherapies - Raises GBP10.3 million from the placing and direct subscription of 97.7 million shares at 10.5 pence each. The amount beats the target set by Scancell late Wednesday. It had hoped to raise at least GBP8.5 million. The placing is run by Panmure Liberum Ltd. Scancell hopes to raise a further GBP1 million from a retail share offer at the same price via the Winterflood Retail Access Platform. Read More